Description: Ambit's proprietary, high-throughput chemical proteomics technology enables the rapid discovery of interactions between small molecules and human proteins. Ambit uses these discoveries to develop proprietary, target-specific small molecule drugs, and to identify new uses for existing drugs and clinical-stage compounds.